-
FDA expert group 7:2 supports the retention of Tecentriq triple-negative breast cancer...
Time of Update: 2021-05-10
In March 2019, PD-L1-positive patients' progression-free survival (PFS) results based on the IMpassion130 study of atelizumab combined with Abraxane (albumin paclitaxel) in the treatment of PD-L1-positive metastatic triple-negative breast cancer (TNBC) (7.
-
How to avoid severe hypoglycemia in elderly patients with type 2 diabetes who started insulin
Time of Update: 2021-05-10
Comment In this study, compared with NPH insulin, the use of long-acting insulin analogues (insulin glargine or insulin detemir) in elderly patients with type 2 diabetes is associated with a lower risk of severe hypoglycemia.
-
Hengrui Medicine's application for the listing of CDK 4/6 inhibitors has been accepted and R&D investment nearly 2...
Time of Update: 2021-05-10
On April 27, the Center for Drug Evaluation (CDE) of the National Medical Products Administration of China announced that Hengrui Medicine's Class 1 new drug CDK 4/6 inhibitor SHR6390 tablets had submitted a new drug marketing application and was accepted.
-
Molecular Cancer | 2 articles in a row!
Time of Update: 2021-05-10
In conclusion, the study found that CircLIFR may interact with MSH2 and positively regulate CDDP sensitivity in bladder cancer through the MutSα/ATM-p73 axis.
-
Microcore Bio-Cidabenamine Lung Cancer Phase 2 Clinical Accepted, Cioroni Approved in China and the U.S.
Time of Update: 2021-05-10
On April 20, Microchip released an announcement that the Phase 2 trial of chidamide combined with envolimab in the treatment of non-small cell lung cancer (NSCLC) patients who have been treated with PD-1 inhibitors has been received from China.
-
Interpretation of Chinese Guidelines for Diabetic Nephropathy (Part 2)
Time of Update: 2021-05-09
Figure 3: How the choice to control proteinuria regulates blood lipids Lowering LDL-c levels can reduce the risk of cardiovascular events in patients with DKD.
-
Prof. Xu Wei: Current status and resistance mechanism of BCL-2 inhibitors in CLL
Time of Update: 2021-05-09
In the phase III clinical trial of the MURANO study, 11 patients also received Venecla treatment after disease progression, and 6 patients achieved remission, with an objective remission rate (ORR) of 55%.
-
Results of two Phase III studies of Bristol-Myers Squibb's oral TYK-2 inhibitor announced (with PPT)
Time of Update: 2021-05-09
binds to the TYK2 protein regulatory domain to make TYK2 in an inactive conformation, thereby inhibiting the activity of TYK2. Since the regulatory domain of TYK2 is different from the regulatory domains of Janus kinase (JAK) 1, 2
-
The cause of the cough cannot be found for 2 years, the "murderer" turned out to be it!
Time of Update: 2021-05-09
Summary: This patient was treated in an outside hospital several times after the operation, and was treated with anti-infective treatment alone, but the bronchopleural fistula was not found in time, which caused the lung infection to persist.
-
Follow up with the new concept of type 2 diabetes prevention and treatment in China, and interpret the updated points of the new CDS 2020 guide
Time of Update: 2021-05-09
The TIR international consensus released in 2019 recommends that the TIR control target for patients with type 1 diabetes (T1DM) and T2DM is >70%, but it should be highly individualized, while paying attention to hypoglycemia and blood glucose fluctuations[14] .
-
Express | Aims to "functionally cure" hepatitis B, phase 2 clinical trial of innovative combination therapy starts
Time of Update: 2021-05-09
▎Brii Biosciences, VIR Biotechnology, and VBI Vaccines, editors of WuXi AppTec's content team, announced today that the Phase 2 clinical trial for the treatment of chronic hepatitis B virus (HBV) infection has completed the first patient administration.
-
NEJM publishes Phase 3 results of Johnson & Johnson's single-dose new crown vaccine: prevent 2/3 of moderate to severe diseases, effective in South Africa
Time of Update: 2021-05-09
S vaccine against moderate to severe new coronavirus disease (COVID-19) reached 66.
-
Drug release: The FDA expert team supports the retention of T drugs for the first-line treatment of mTNBC with 7:2
Time of Update: 2021-05-08
Drug Advisory Committee (ODAC) voted 7:2 (for: against) to support the approval to stay in the market. Based on data from a clinical study called IMpassion130, in March 2019, the FDA accelerated the approval
-
LANCET: The complete elimination of SARS-CoV-2 can create the best results for health, economy and civil liberties
Time of Update: 2021-05-08
-19 . Those countries that have always aimed at eradication—that is, taking maximum action to control SARS-CoV-2 and stopping the spread of the community as soon as possible—in general are making
-
FDA expert group 7:2 supports the retention of Tecentriq triple-negative breast cancer indication
Time of Update: 2021-05-08
In March 2019, PD-L1-positive patients' progression-free survival (PFS) results based on the IMpassion130 study of atelizumab combined with Abraxane (albumin paclitaxel) in the treatment of PD-L1-positive metastatic triple-negative breast cancer (TNBC) (7.
-
Nat Commun.: Genes related to decreased muscle function in type 2 diabetes (sarcopenia) have been confirmed
Time of Update: 2021-05-08
Recently, a research team from Lund University in Sweden discovered that in patients with type 2 diabetes, a specific gene is very important for the ability of muscle stem cells to create new mature muscle cells.
-
Announcement of Nantong City Food Safety Supervision Sampling Inspection Results in 2021 (Phase 2)
Time of Update: 2021-05-08
html" class="zdbq" title="Dairy related food information" target="_blank">dairy products , foodmate.
html" class="zdbq" title="Dairy related food information" target="_blank">dairy products , foodmate.
-
Announcement of Maoming City Market Supervision Administration on 7 batches of unqualified foods (Phase 2 of 2021)
Time of Update: 2021-05-08
html" class="zdbq" title="Edible oil related food information" target="_blank">、foodmate.
html" class="zdbq" title="Food information related to starch products" target="_blank">、foodmate.
-
Liver Int: The effect of direct antiviral therapy on long-term blood glucose control of type 2 diabetes with chronic hepatitis or cirrhosis
Time of Update: 2021-05-07
diabetesThis study aims to evaluate the effect of anti-HCV direct-acting antiviral (DAA) treatment on long-term blood glucose control in patients with chronic hepatitis C (CHC) or cirrhosis of type 2 diabetes (HCV/T2DM) .
-
£2 million: The University of Nottingham will develop a new type of aerospace ceramic coating
Time of Update: 2021-05-07
Hussain will develop new chemical methods for ceramic coatings to make rocket engines more efficient and reusable, thereby opening the door for humans to travel in deep space.
